Related Experiment Video

Updated: May 26, 2026

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
09:47

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

Published on: June 2, 2022

Paediatric cardiomyopathy and anaesthesia

R J Ing1, W A Ames, N A Chambers

  • 1Department of Anesthesiology, Children's Hospital Colorado, Anschutz Medical Campus, 13123 East 16th Ave., Aurora, CO 80045, USA.

British Journal of Anaesthesia
|December 14, 2011
PubMed

Insights

Pediatric cardiomyopathy (CM) poses significant anesthesia risks. This review details CM types, focusing on anesthetic management strategies for children with dilated, hypertrophic, and restrictive forms.

Area of Science:

  • Pediatric Cardiology
  • Anesthesiology
  • Cardiovascular Medicine

Background:

  • Cardiomyopathy (CM) is a myocardial disease causing cardiac dysfunction, posing risks in pediatric anesthesia.
  • Undiagnosed CM can lead to cardiac arrest during anesthesia in children.
  • Managing pediatric CM requires tailored anesthetic goals to maintain hemodynamic stability.

Purpose of the Study:

  • To review the pathology, etiology, and clinical presentation of different pediatric cardiomyopathy forms.
  • To examine recent therapeutic advances, including end-stage disease management.
  • To highlight specific anesthetic considerations for children with various CM types.

Main Methods:

  • Review of current literature on pediatric cardiomyopathy.
  • Analysis of diagnostic tools and cardiac imaging advancements.
  • Examination of evolving treatment modalities, including ventricular assist devices.

Main Results:

  • Dilated, hypertrophic, and restrictive cardiomyopathies are the most common forms in children.
  • Anesthetic management must address specific hemodynamic needs for each CM type.
  • Advances in diagnostics and therapeutics are refining anesthetic care.

Conclusions:

  • Understanding specific CM types is crucial for safe pediatric anesthesia.
  • Tailored anesthetic strategies are essential for optimizing outcomes in children with CM.
  • Ongoing advancements necessitate continuous updates in anesthetic management protocols.

More Related Videos

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...